FindTrial
Sign In

A study on drug therapy and participantâ??s outlook on acne vulgaris

A study on drug therapy and participant perspectives on acne vulgaris

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/11/047301
Enrollment
178
Registered
2022-11-15
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age >= 10 years. Participants who are willing to participate. Participants who have any type of acne vulgaris, including open comedones, closed comedones, papules, pustules, nodules, cysts etc.

Exclusion criteria

Exclusion criteria: Participants having any skin condition other than acne vulgaris. Participants who are not willing to grant consent.

Design outcomes

Primary

MeasureTime frame
To study the prescribing pattern for acne according to GAGS.Timepoint: Single Point—

Secondary

MeasureTime frame
To assess the participantâ??s concern regarding acne.Timepoint: Single Point—

Countries

India

Contacts

Public ContactDr Tonita M Noronha

NGSM Institute of Pharmaceutical Sciences, NITTE (Deemed to be university)

junojoel@nitte.edu.in9480470727

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026